PRAZIQUANTEL Drug Patent Profile
✉ Email this page to a colleague
When do Praziquantel patents expire, and when can generic versions of Praziquantel launch?
Praziquantel is a drug marketed by Par Pharm Inc and is included in one NDA.
The generic ingredient in PRAZIQUANTEL is praziquantel. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the praziquantel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Praziquantel
A generic version of PRAZIQUANTEL was approved as praziquantel by PAR PHARM INC on November 27th, 2017.
Summary for PRAZIQUANTEL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 146 |
Clinical Trials: | 50 |
Patent Applications: | 3,125 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PRAZIQUANTEL |
DailyMed Link: | PRAZIQUANTEL at DailyMed |
Recent Clinical Trials for PRAZIQUANTEL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
London School of Hygiene and Tropical Medicine | N/A |
Université de Thies, UFR Santé, Senegal | N/A |
University of North Carolina, Chapel Hill | N/A |
Pharmacology for PRAZIQUANTEL
Drug Class | Anthelmintic |
Medical Subject Heading (MeSH) Categories for PRAZIQUANTEL
Anatomical Therapeutic Chemical (ATC) Classes for PRAZIQUANTEL
US Patents and Regulatory Information for PRAZIQUANTEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Pharm Inc | PRAZIQUANTEL | praziquantel | TABLET;ORAL | 208820-001 | Nov 27, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |